Bulldog Investors’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Bulldog Investors’s Portfolio RVPHW Stock Details RVPHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-23,358	Closed	-$2K	–	144
2020 Q1	$2K	Sell	23,358 -30,947	-57%	-$4.63K	﹤0.01%	144
2019 Q4	$5K	Hold	54,305	–	–	﹤0.01%	154
2019 Q3	$10K	Hold	54,305	–	–	﹤0.01%	147
2019 Q2	$11	Hold	54,305	–	–	﹤0.01%	156
2019 Q1	$9K	Hold	54,305	–	–	﹤0.01%	140
2018 Q4	$18K	Buy	+54,305	New	+$17.4K	0.01%	140

Other funds holding RVPHW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Bulldog Investors's RVPHW Position: Q2 2020 in Review

Bulldog Investors sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q2 2020, closing a stake of 23,358 shares — an estimated $2K sold.

Bulldog Investors first reported a position in RVPHW in Q4 2018 and held it in 6 quarters. The position peaked at $18K in Q4 2018. 17 funds tracked by Wall St. Rank hold RVPHW as of Q2 2020.

Bulldog Investors reported no remaining Reviva Pharmaceuticals Warrants position as of Q2 2020 after selling out during the quarter.
Bulldog Investors sold 23,358 Reviva Pharmaceuticals Warrants shares in Q2 2020, an estimated $2K.
Bulldog Investors first reported a position in Reviva Pharmaceuticals Warrants in Q4 2018 and held it in 6 quarters.
Bulldog Investors's Reviva Pharmaceuticals Warrants position peaked at $18K in Q4 2018.
17 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q2 2020.

Based on Bulldog Investors's 13F filing for Q2 2020, filed 13 Aug 2020.